Related Experiment Video
Updated: Jun 6, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
[Biological effects of endostatin on vascular endothelial cell and fibroblast]
1Department of Cardiothoracic Surgery , The General Hospital , Tianjin Medical University , Tianjin 300052, P . R. China.
Background:
To study the proliferation-inhibiting and apoptosis-inducing effects of recombinant human endostatin on both human umbilical vein endothelial cell ECV304 and fibroblast WI-38, and to investigate the efficacy, specificity and possible mechanisms of cell proliferation-inhibiting effect of endostatin.
Methods:
The different cells were cultured for a period of time in different kinds of culture fluids containing endostatin. The modality of the cells, proliferation-inhibiting rate and apoptosis degree were observed by MTT-cell proliferation detection and ELISA-cell death detection methods.
Results:
Recombinant human endostatin strikingly inhibited ECV304 cell proliferation in a dose-dependent manner, with an ED₅₀ value range from 15 to 20μg/ml, and it also strongly induced ECV304 cell apoptosis ( enrichment factor 2. 44) . No similar results were obtained in WI-38 cell.
Conclusions:
Recombinant human endostatin can inhibit vascular endothelial cell proliferation specifically, and one of the possible mechanisms may be its apoptosis-inducing effect.
Insights
Recombinant human endostatin specifically inhibits endothelial cell proliferation and induces apoptosis. This targeted effect on vascular endothelial cells (ECV304) suggests potential therapeutic applications, unlike its impact on fibroblasts (WI-38).
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Context:
- Endostatin is a potent anti-angiogenic factor.
- Understanding its cellular effects is crucial for therapeutic development.
- Investigating endostatin's impact on endothelial cells and fibroblasts provides insights into its specificity.
Purpose:
- To evaluate the proliferation-inhibiting and apoptosis-inducing effects of recombinant human endostatin.
- To determine the efficacy and specificity of endostatin's anti-proliferative action.
- To explore the underlying mechanisms of endostatin's effects on ECV304 and WI-38 cells.
Summary:
- Recombinant human endostatin significantly inhibited human umbilical vein endothelial cell (ECV304) proliferation in a dose-dependent manner (ED₅₀: 15-20μg/ml).
- Endostatin strongly induced apoptosis in ECV304 cells, with an enrichment factor of 2.44.
- No significant inhibitory or apoptotic effects were observed in human fibroblast (WI-38) cells, indicating specificity.
Impact:
- Recombinant human endostatin demonstrates specific anti-proliferative activity against vascular endothelial cells.
- Apoptosis induction is a key mechanism underlying endostatin's anti-proliferative effects.
- These findings support endostatin's potential as a targeted therapeutic agent in angiogenesis-related diseases.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...

